Pennsylvania SB 1149: An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for authority to control.
Status: Referred to Judiciary (as of 2026-01-23)
State: Pennsylvania · Session: 2025-2026 · Bill: SB 1149
Sponsors: Tracy Pennycuick, Camera Bartolotta, Devlin Robinson, Elder Vogel, Joe Picozzi, Judy Ward, Lynda Schlegel Culver, Nikil Saval, Patrick Stefano, Rosemary Brown, Timothy Kearney
Bill Text
PRINTER'S NO. 1398 THE GENERAL ASSEMBLY OF PENNSYLVANIA SENATE BILL No. 1149 Session of 2026 INTRODUCED BY PENNYCUICK, BARTOLOTTA, ROBINSON, VOGEL, KEARNEY, J. WARD, STEFANO, PICOZZI, BROWN, CULVER AND SAVAL, JANUARY 23, 2026 REFERRED TO JUDICIARY, JANUARY 23, 2026 AN ACT Amending the act of April 14, 1972 (P.L.233, No.64), entitled "An act relating to the manufacture, sale and possession of controlled substances, other drugs, devices and cosmetics; conferring powers on the courts and the secretary and Department of Health, and a newly created Pennsylvania Drug, Device and Cosmetic Board; establishing schedules of controlled substances; providing penalties; requiring registration of persons engaged in the drug trade and for the revocation or suspension of certain licenses and registrations; and repealing an act," further providing for authority to control. The General Assembly of the Commonwealth of Pennsylvania hereby enacts as follows: Section 1. Section 3 of the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, is amended by adding a subsection to read: Section 3. Authority to Control.--* * * (b.1) Notwithstanding subsection (a) or (c)(1), immediately upon approval by the United States Food and Drug Administration, the pharmaceutical composition of synthetic psilocybin shall be scheduled in a manner to coincide with Federal law, including 21 U.S.C. Ch. 13 Subch. I (relating to control and enforcement), 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 regulations promulgated under 21 CFR Ch. II (relating to drug enforcement administration, Department of Justice) or any Federal judicial order. Within five business days following rescheduling by the United States Drug Enforcement Administration of the pharmaceutical composition of synthetic psilocybin, the secretary shall transmit notice of the rescheduling to the Legislative Reference Bureau for publication in the next available issue of the Pennsylvania Bulletin. The rescheduling shall take effect thirty days after the publication in the Pennsylvania Bulletin. * * * Section 2. This act shall take effect immediately. 20260SB1149PN1398 - 2 - 1 2 3 4 5 6 7 8 9 10 11 12
View Pennsylvania SB 1149 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.